國立虎尾科技大學 |

Integrative Medicine for Breast Cancer = An Evidence-Based Assessment /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Integrative Medicine for Breast Cancer/ by Mark A. Moyad.
其他題名:	An Evidence-Based Assessment /
作者:	Moyad, Mark A.
面頁冊數:	X, 395 p.online resource. :
Contained By:	Springer Nature eBook
標題:	Oncology . -
電子資源:	https://doi.org/10.1007/978-3-319-23422-9
ISBN:	9783319234229

Integrative Medicine for Breast Cancer = An Evidence-Based Assessment /
Moyad, Mark A.

Integrative Medicine for Breast CancerAn Evidence-Based Assessment /[electronic resource] :by Mark A. Moyad. - 1st ed. 2016. - X, 395 p.online resource.

Chapter 1 -- Introduction -- Chapter 2 25+ Observations over 25+ years for Surviving & Thriving in the Dietary Supplement Quality Control &/or Perception vs. Reality World -- Chapter 3 -- The Ideal 7-Step Breast Cancer Diet, Lifestyle & Dietary Supplements Program for Prevention/Recurrence: Heart Healthy=Breast Healthy -- Chapter 4 -- S.A.M & Breast Cancer-Focus on Statins, Red Yeast Rice, Sterols & Other Integrative Cholesterol Medicines: The Real “Natural” Options -- Chapter 5 S.A.M. & BREAST CANCER-Focus on Aspirin & Other Integrative Aspirin-like Medicines: The Real “Natural” Options -- Chapter 6 S.A.M. & BREAST CANCER-Focus on Metformin & Other Integrative Metformin-Mimic Medicines: The Real “Natural” Options -- Chapter 7 Rapid Review of Breast Cancer Treatment Side Effects and Dietary Supplement/Integrative Options from A to Z: What helps, harms, or does nothing -- Chapter 8 Supplements/Diet/Other Integrative Method Vernacular & Controversies from A to Z: What is the latest or greatest, or not so great.

This book is designed to capture and clinically review the comprehensive database of clinical research articles that support and do not support the utilization of a variety of dietary supplements and other complementary medicines that physicians are exposed to in their daily practice. The growing list of CAM products that could interfere with surgery (anesthesia, bleeding, outcomes…) and/or conventional medicines is very large and is provided in each section of the book. Additionally, the list of dietary supplements that could be utilized to improve quality of life for breast cancer patients is also emphasized. The various sub-specialty groups in breast are adequately represented, which allows for a physician to rapidly and thoroughly investigate their topic of interest regardless of whether the topic is prevention, treatment, or a specific side effect of treatment. The practical nature of this book cannot be overstated. Chapters include a general overview of the CAM agent, whether or not it has data in medicine and oncology, and a list of potential drug interactions and specific clinical scenarios where it can be utilized or discouraged in the specialty. Each chapter also includes a rapid review A to Z table that covers the clinical take home points for each subject reviewed in each chapter.

ISBN: 9783319234229

Standard No.: 10.1007/978-3-319-23422-9doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Integrative Medicine for Breast Cancer = An Evidence-Based Assessment /
LDR:03668nam a22003975i 4500 001 978730
003 DE-He213
005 20200629193919.0
007 cr nn 008mamaa
008 201211s2016 gw | s |||| 0|eng d
020 $a 9783319234229 $9 978-3-319-23422-9
024 7 $a 10.1007/978-3-319-23422-9 $2 doi
035 $a 978-3-319-23422-9
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
100 1 $a Moyad, Mark A. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1021474
245 1 0 $a Integrative Medicine for Breast Cancer $h [electronic resource] : $b An Evidence-Based Assessment / $c by Mark A. Moyad.
250 $a 1st ed. 2016.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a X, 395 p. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1 -- Introduction -- Chapter 2 25+ Observations over 25+ years for Surviving & Thriving in the Dietary Supplement Quality Control &/or Perception vs. Reality World -- Chapter 3 -- The Ideal 7-Step Breast Cancer Diet, Lifestyle & Dietary Supplements Program for Prevention/Recurrence: Heart Healthy=Breast Healthy -- Chapter 4 -- S.A.M & Breast Cancer-Focus on Statins, Red Yeast Rice, Sterols & Other Integrative Cholesterol Medicines: The Real “Natural” Options -- Chapter 5 S.A.M. & BREAST CANCER-Focus on Aspirin & Other Integrative Aspirin-like Medicines: The Real “Natural” Options -- Chapter 6 S.A.M. & BREAST CANCER-Focus on Metformin & Other Integrative Metformin-Mimic Medicines: The Real “Natural” Options -- Chapter 7 Rapid Review of Breast Cancer Treatment Side Effects and Dietary Supplement/Integrative Options from A to Z: What helps, harms, or does nothing -- Chapter 8 Supplements/Diet/Other Integrative Method Vernacular & Controversies from A to Z: What is the latest or greatest, or not so great.
520 $a This book is designed to capture and clinically review the comprehensive database of clinical research articles that support and do not support the utilization of a variety of dietary supplements and other complementary medicines that physicians are exposed to in their daily practice. The growing list of CAM products that could interfere with surgery (anesthesia, bleeding, outcomes…) and/or conventional medicines is very large and is provided in each section of the book. Additionally, the list of dietary supplements that could be utilized to improve quality of life for breast cancer patients is also emphasized. The various sub-specialty groups in breast are adequately represented, which allows for a physician to rapidly and thoroughly investigate their topic of interest regardless of whether the topic is prevention, treatment, or a specific side effect of treatment. The practical nature of this book cannot be overstated. Chapters include a general overview of the CAM agent, whether or not it has data in medicine and oncology, and a list of potential drug interactions and specific clinical scenarios where it can be utilized or discouraged in the specialty. Each chapter also includes a rapid review A to Z table that covers the clinical take home points for each subject reviewed in each chapter.
650 0 $a Oncology . $3 1253469
650 0 $a Endocrinology . $3 1254221
650 1 4 $a Oncology. $3 593951
650 2 4 $a Endocrinology. $3 645497
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319234212
776 0 8 $i Printed edition: $z 9783319234236
776 0 8 $i Printed edition: $z 9783319363899
856 4 0 $u https://doi.org/10.1007/978-3-319-23422-9
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)